Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study (Q33409866)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study |
scientific article |
Statements
1 reference
Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study (English)
1 reference
Antonio Palumbo
1 reference
Sara Bringhen
1 reference
Davide Rossi
1 reference
Claudia Crippa
1 reference
Roberto Mina
1 reference
Monica Galli
1 reference
Magda Marcatti
1 reference
Giacinto La Verde
1 reference
Valeria Magarotto
1 reference
Tommasina Guglielmelli
1 reference
Delia Rota-Scalabrini
1 reference
Paola Omedé
1 reference
Alberto Santagostino
1 reference
Angelo Michele Carella
1 reference
Mario Boccadoro
1 reference
16 August 2013
1 reference
1 reference
122
1 reference
16
1 reference
2799-2806
1 reference
Identifiers
1 reference
1 reference